Home/Filings/4/0001213900-20-011996
4//SEC Filing

David Matthew T 4

Accession 0001213900-20-011996

CIK 0001410098other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 4:18 PM ET

Size

8.0 KB

Accession

0001213900-20-011996

Insider Transaction Report

Form 4
Period: 2020-05-11
David Matthew T
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy Common Stock)

    2020-05-11$5.63/sh+125,000$703,750125,000 total
    Exercise: $5.63Exp: 2030-05-11Common Stock (125,000 underlying)
  • Award

    Stock Option (Right to Buy Common Stock)

    2020-05-11$4.08/sh+125,000$510,000125,000 total
    Exercise: $4.08Exp: 2030-05-11Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeother

Related Parties

1
  • filerCIK 0001811612

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:18 PM ET
Size
8.0 KB